Quarterly report pursuant to Section 13 or 15(d)

FINANCIAL INSTRUMENTS (Tables)

v3.24.1.u1
FINANCIAL INSTRUMENTS (Tables)
3 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The following table presents the classification of the Company’s financial instruments that are required to be measured at fair value on a recurring basis on the Company’s Condensed Consolidated Balance Sheets (in thousands):
March 31, 2024 December 31, 2023
Current assets:
Natural gas financial instruments $ —  $ — 
Current liabilities:
Embedded derivatives 7,183  13,332 
Long-term liabilities:
Embedded derivatives 11,329  18,892 
Schedule of Derivative Instruments, Gain (Loss)
The following table summarizes the effect of the Company’s financial instruments on the Condensed Consolidated Statements of Operations (in thousands):
Three Months Ended March 31,
2024 2023
Natural gas financial instruments:
Realized gain $ —  $ 11,866 
Unrealized loss —  428 
Contingent Consideration:
Realized gain —  118 
Embedded Derivatives
Realized loss 2,145  — 
Unrealized loss 1,959  — 
Schedule of Derivative Instruments
The following table summarizes changes in the Company’s Embedded Derivatives (in thousands):
Three Months Ended March 31, 2024
Balance at January 1, 2024 $ 32,225 
Issued — 
Settled (17,817)
Total gains or losses (realized and unrealized) included in earnings 4,103 
Balance at March 31, 2024
$ 18,511